Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: AS Grindeks, Krustpils Iela 53, Riga, 1057, Latvia
Ursogrix 250 mg hard capsules.
| Pharmaceutical Form |
|---|
|
Capsule, hard. White hard gelatin capsules size 0, approximately 21.7 mm x 7.64 mm. The content – white or almost white powder. |
Each hard capsule contains 250 mg ursodeoxycholic acid.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ursodeoxycholic acid |
The ursodeoxycholic acid converts lithogenic bile in non-lithogenic bile and gradually dissolves the cholesterol gallstones. |
| List of Excipients |
|---|
|
Maize starch Hard gelatin capsule: Body and cap composition |
The capsules are packed in PVC/aluminium blisters.
10 capsules per blister. 5, 6 or 10 blisters (50, 60 or 100 capsules) are packed per cardboard box.
Not all pack sizes may be marketed.
AS Grindeks, Krustpils Iela 53, Riga, 1057, Latvia
PA22992/002/001
Date of first authorisation: 26th February 2021
Date of last renewal: 21st December 2021
| Drug | Countries | |
|---|---|---|
| URSOGRIX | Austria, Estonia, Croatia, Ireland, Lithuania, Malta, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
